Portfolio company
The Vaccine Group
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops recombinant viral-vector vaccines and biotherapeutics for livestock and companion animals to control infectious and chronic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ViroVet
This company develops vaccines and antiviral drugs for livestock to control respiratory diseases and other viral infections in cattle, swine, sheep and goats.
Intervacc
Intervacc develops and supplies recombinant protein vaccines and medicines for horses and livestock to veterinarians and animal owners.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
Okapi Sciences
The company develops antiviral drugs for veterinary applications to treat viral infections in pets and livestock.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
TEORA
This company develops orally delivered vaccines and biologics for aquaculture, livestock and agriculture customers to prevent diseases and enhance growth.
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
Aptimmune
This company develops and manufactures mucosal vaccines for the global commercial swine industry to prevent viral respiratory diseases in livestock.
